Transaction Overview

Janney Montgomery Scott (“Janney”) served as the exclusive financial advisor to AlphaGroup Medical Communications (“AlphaGroup”) in its sale to Red Nucleus.

AlphaGroup is renowned for delivering leading scientific, medical affairs, and outcomes communication services for the pharmaceutical, biotech, and medical device/diagnostic industries. The Company’s services are high-science, with over half of its employees awarded advanced scientific degrees. AlphaGroup has expansive therapeutic expertise in oncology, virology, transplantation, immunology, rare diseases, gene therapy, and cardiology.

Stephen Douthwaite, founder of AlphaGroup said, “The Janney team provided us with expert guidance throughout the journey and I am thrilled for AlphaGroup to be joining with Red Nucleus.”

About AlphaGroup

AlphaGroup, founded in 2005, provides a focused set of scientific and medical communications solutions centered on key medical activities throughout a product’s lifecycle, beginning in pre-clinical development and spanning through FDA approval, product launch and continued marketing efforts. The Company brings expertise in the areas of scientific medical communications, medical affairs communications, and health economics and outcomes research (HEOR), real world evidence (RWE), and payer communications. For more information on AlphaGroup, visit

About Red Nucleus

Red Nucleus is a premier provider of strategic learning and development, scientific services and advisory, medical communications solutions, and market access and commercialization services exclusively for the life sciences industry. For more information on Red Nucleus, visit

Contact us for more information

David K. Reed

Managing Director, Investment Banking

Contact David K. Reed

For more information about Janney, please see Janney’s Relationship Summary (Form CRS) on which details all material facts about the scope and terms of our relationship with you and any potential conflicts of interest.

To learn about the professional background, business practices, and conduct of FINRA member firms or their financial professionals, visit FINRA’s BrokerCheck website: